Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2007
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics
12/25/2007US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy
12/25/2007US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
12/21/2007WO2007146977A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007WO2007146602A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
12/21/2007WO2007146087A2 SUBSTITUTED PYRAZOLO [1,5-α] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE
12/21/2007WO2007145326A1 Method for determination of inflammatory disease
12/21/2007WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007WO2007145253A1 NF-ϰB ACTIVATION INHIBITOR
12/21/2007WO2007144379A1 Bicyclic compounds useful as cathepsin s inbhibitors
12/21/2007WO2007144203A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007WO2007144127A1 Pyrrole derivatives with crth2 receptor modulator activity
12/21/2007WO2007126771A3 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
12/21/2007WO2007124181A3 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
12/21/2007WO2007123939A3 Novel arylamino n-heteraryls as mek inhibitors
12/21/2007WO2007118963A3 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
12/21/2007WO2007050271A3 5-lipoxygenase modulators
12/21/2007WO2007016338A3 Use of chk2 kinase inhibitors for cancer treatment
12/21/2007CA2784304A1 Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
12/21/2007CA2655488A1 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative
12/21/2007CA2655315A1 2-anilino-4-aminoalkyleneaminopyrimidines
12/21/2007CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007CA2654498A1 Substituted pyrazolo[1,5-.alpha.]pyridine compounds and their methods of use
12/21/2007CA2654327A1 Pyrrole derivatives with crth2 receptor modulator activity
12/21/2007CA2654105A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/21/2007CA2653654A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
12/21/2007CA2652669A1 Benzazepinones as sodium channel blockers
12/21/2007CA2650666A1 Substituted cyanopyridines as protein kinase inhibitors
12/20/2007US20070294107 Uses Of Endopeptidases In Treatment Of Disease
12/20/2007US20070293570 Pharmaceutical uses for alpha2delta ligands
12/20/2007US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007US20070293548 Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
12/20/2007US20070293544 Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
12/20/2007US20070293542 Selective Cox-2 Inhibitors
12/20/2007US20070293541 CB1 cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
12/20/2007US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
12/20/2007US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade
12/20/2007US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293522 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
12/20/2007US20070293520 2,4-pyrimidinediamine compounds and their uses
12/20/2007US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound
12/20/2007US20070293484 Thiophene Heteroaryl Amines
12/20/2007US20070293477 Novel Compounds
12/20/2007US20070293457 Boron-containing small molecules as anti-inflammatory agents
12/20/2007US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007US20070292539 Anti-inflammatory cranberry flavonol extract preparations
12/20/2007US20070292442 Using cation exchange to separate host cell protein (HCP) form preferential antibody on chromatographic column
12/20/2007US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/20/2007US20070292429 Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
12/20/2007DE102006027793A1 Opioid-Kombinations-Wafer Opioid combination wafer
12/20/2007DE102006027229A1 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxylic acid amides and their use for the preparation of medicaments
12/20/2007CA2635467A1 Bst2 inhibitor
12/20/2007CA2602555A1 Composition and method for reducing inflammation
12/19/2007EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use
12/19/2007EP1867718A2 Therapeutically useful synthetic oligonucleotides
12/19/2007EP1867644A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
12/19/2007EP1866325A2 Novel crystalline pharmaceutical product
12/19/2007EP1866311A2 Novel compounds
12/19/2007EP1866310A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
12/19/2007EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors
12/19/2007EP1866305A1 1,7-naphthyridines as pde4 inhibitors
12/19/2007EP1866286A1 Pyridine derivatives useful as inhibitors of pkc-theta
12/19/2007EP1866278A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
12/19/2007EP1865982A1 Hydrogel composition for modulation of topical inflammatory response
12/19/2007EP1865963A2 Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor
12/19/2007EP1865933A1 Low-concentration capsaicin patch and methods for treating neuropathic pain
12/19/2007EP1865774A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/19/2007EP1592426B1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
12/19/2007EP1558262B1 Water-soluble meloxicam granulates
12/19/2007EP1551370B1 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
12/19/2007EP1503757B1 Tyrosine kinase inhibitors
12/19/2007EP1496911B1 Use of a combination comprising a2a adenosine receptor agonists and anti-pathogenic agents for the treatment of inflammatory diseases
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007EP1434567B1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/19/2007EP1339665B1 Nitroderivatives as drugs for diseases having an inflammatory basis
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1305435B1 Use of herpes simplex virus glycoprotein d to suppress immune responses
12/19/2007EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists
12/19/2007EP1095061B1 Peptides based on the sequence of human lactoferrin and their use
12/19/2007CN200991422Y Recovering medicinal plaster
12/19/2007CN101090908A Conjugates with anti-inflammatory activity
12/19/2007CN101090900A Process for preparation of high-purity meloxicam and meloxicam potassium salt
12/19/2007CN101090731A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
12/19/2007CN101089000A Spiro piperazine quaternary ammonium salt compound and its prepn and application
12/19/2007CN101088539A Externally applied Chinese medicine composition for treating rheumatic arthritis and calcification of posterior longitudinal ligament of vetebral body
12/19/2007CN101088500A Cold treating medicine for children
12/19/2007CN100355776C Novel alpha-melanocyte stimulating hormone analogue and use thereof
12/19/2007CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
12/19/2007CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
12/19/2007CN100355748C Aromatic hydrazide kind compound and its use in preparation of immune inhibitor
12/19/2007CN100355738C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
12/19/2007CN100355728C Inhibitors of dipeptidyl peptidase IV
12/19/2007CN100355443C Medicinal liquor for treating wind-cold, numbness and swelling pain disease
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists